Hepatocellular Carcinoma in Korea Between 2008 and 2011: an Analysis of Korean Nationwide Cancer Registry.
Jun Sik YoonHan Ah LeeJun Yong ParkBo Hyun KimIn Joon LeeYoung Eun ChonSuk Kyun HongDong Hyeon LeeHyun-Joo KongYoung-Joo WonEunyang KimJeong-Hoon LeePublished in: Journal of liver cancer (2020)
Between 2008 and 2011, approximately half of patients with HCC (48.3%) were candidates for curative treatment (BCLC stage 0 or A), but one-third of patients (33.8%) had advanced HCC (BCLC stage C). Transarterial therapy was the most commonly conducted initial treatment and the 5-year OS rate was 36.8% in this period.